Managers / Q3 2022 · view latest →
Avenir Management Company, LLC
CIK 0001866419 · 817 BROADWAY, 12TH FLOOR, NEW YORK, NY, 10003 · 516-318-6545
Summary
Avenir Management Company, LLC reported $59M in U.S.-listed holdings across 6 positions for Q3 2022.
The portfolio is heavily concentrated: LTCH alone accounts for 34.6% of reported value.
The book was largely unchanged from Q2 2022.
Portfolio Metrics
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded, with multiple share classes and repeated sub-manager rows for the same issuer combined into one position — the same rule the holdings table uses by default. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
Portfolio Composition
- Common Stock · 95.3% · $56M
- Other · 4.7% · $3M
Quarter-over-Quarter Changes full breakdown →
vs Q2 2022 (amended baseline)
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| LTCHLATCH INC | HELD | +0 | 21.44M | −$4M | $20M |
| GLOBAL E ONLINE LTD | HELD | +0 | 484.3K | +$3M | $13M |
| SNOWSNOWFLAKE INC | HELD | +0 | 81.0K | +$3M | $14M |
| FINCH THERAPEUTICS GROUP INC | HELD | +0 | 1.66M | −$2M | $3M |
| UBERUBER TECHNOLOGIES INC | HELD | +0 | 183.3K | +$1M | $5M |
| CVNACARVANA CO | HELD | +0 | 201.2K | −$459,000 | $4M |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q3 2022
| # | Issuer | Class | % Portfolio | Value ↓ | Shares |
|---|---|---|---|---|---|
| 1 | LTCHLATCH INChistory → | COM | 34.63% | $20M | 21.44M |
| 2 | SNOWSNOWFLAKE INChistory → | CL A | 23.40% | $14M | 81.0K |
| 3 | GLOBAL E ONLINE LTD | SHS | 22.04% | $13M | 484.3K |
| 4 | UBERUBER TECHNOLOGIES INChistory → | COM | 8.26% | $5M | 183.3K |
| 5 | CVNACARVANA COhistory → | CL A | 6.94% | $4M | 201.2K |
| 6 | FINCH THERAPEUTICS GROUP INC | COM | 4.72% | $3M | 1.66M |
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q3 2023 | $44M | 4 | Nov 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q2 2023 | $37M | 4 | Aug 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q1 2023 | $20M | 4 | May 15, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q4 2022 | $43M | 6 | Feb 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q3 2022 | $59M | 6 | Nov 14, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q2 2022 | $58M | 6 | Aug 15, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q1 2022 | $109M | 4 | May 16, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q4 2021 | $187M | 3 | Feb 14, 2022 | 13F-HR | changes · EDGAR ↗ |
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.